◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
French biotech stock soars 34% after new data on experimental medicine
7sources
7articles
5velocity
+0%since first seen
20d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (7)
- Abivax aims to set cancer concerns with ulcerative colitis drug to rest Endpoints News · 21d ago
- Abivax rebounds from stock drop with safety data for much-hyped colitis prospect Fierce Biotech · 21d ago
- Biggest stock movers Tuesday: Crypto stocks, FCEL, ABVX, and more Seeking Alpha · 21d ago
- Abivax seeks to ease safety concerns with new data, boosting shares statnews.com · 21d ago
- Abivax stock surges on obefazimod safety data, cancer concerns qz.com · 21d ago
- ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data Yahoo Finance · 21d ago
- French biotech stock soars 34% after new data on experimental medicine CNBC · 21d ago
Related trends
▲ Peaking
Business
Five US tech giants' hidden debts soar to $1.65tn on opaque AI funding
Five US tech giants are facing scrutiny as hidden debts tied to opaque AI funding surge to $1.65 trillion.
▲ Peaking
Business
Trump agrees to ethics provision as crypto bill inches closer to Senate vote
▲ Peaking
Business
Sen. Chuck Schumer hopes to slash meat prices at the grocery store with new bill
Senator Chuck Schumer and cosponsor Balint introduce legislation to break up meatpacking monopolies to lower grocery costs.
▲ Peaking
Business
Apple’s stunning Nvidia flip reveals where AI money is moving
▲ Peaking
Business
Chip Rebound Drives Stocks Higher as Oil Eases: Markets Wrap
▲ Peaking
Business